Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

BACKGROUND: Patients with Ph-negative myeloproliferative neoplasms (MPN), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at increased risk for thrombosis/thromboembolism and major bleeding. Due to the morbidity and mortality of these events, anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaifie, A., Kirschner, M., Wolf, D., Maintz, C., Hänel, M., Gattermann, N., Gökkurt, E., Platzbecker, U., Hollburg, W., Göthert, J. R., Parmentier, S., Lang, F., Hansen, R., Isfort, S., Schmitt, K., Jost, E., Serve, H., Ehninger, G., Berdel, W. E., Brümmendorf, T. H., Koschmieder, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779229/
https://www.ncbi.nlm.nih.gov/pubmed/26944254
http://dx.doi.org/10.1186/s13045-016-0242-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779229/
https://www.ncbi.nlm.nih.gov/pubmed/26944254
http://dx.doi.org/10.1186/s13045-016-0242-9

Ejemplares similares